| Literature DB >> 36001575 |
Nuri Lee1, Seri Jeong1, Kibum Jeon2, Wonkeun Song1, Min-Jeong Park1.
Abstract
BACKGROUND: Protein electrophoresis (PEP) is an important tool in supporting the analytical characterization of protein status in diseases related to monoclonal components, inflammation, and antibody deficiency. Here, we developed a deep learning-based PEP classification algorithm to supplement the labor-intensive PEP interpretation and enhance inter-observer reliability.Entities:
Mesh:
Year: 2022 PMID: 36001575 PMCID: PMC9401151 DOI: 10.1371/journal.pone.0273284
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Dataset preparation and proposed framework.
Demographic statistics and diagnostic classification of protein electrophoresis datasets.
| Densitogram PEP (N = 1289) | Gel PEP (N = 1289) | |||
|---|---|---|---|---|
| Training and Validation | Test | Training and Validation | Test | |
| Age (year) | 67.0 (55.0–77.0) | 66.0 (51.0–75.5) | 67.0 (55.0–76.3) | 64.0 (52.0–78.0) |
| Sex (Male:Female) | 604 : 557 | 68 : 60 | 610 : 551 | 62 : 66 |
| Total protein (mg/dL) | 6.4 (5.6–7.2) | 6.4 (5.6–7.2) | 6.2 (5.5–7.0) | 6.4 (5.6 0 7.3) |
| Albumin (mg/dL) | 3.4 (2.7–3.9) | 3.3 (2.7–3.8) | 3.3 (2.7–3.8) | 3.2 (2.7–3.8) |
| Total no. of EP images | 1161 | 128 | 1161 | 128 |
| Diagnosis | ||||
| Acute-phase protein | 69 (5.9%) | 5 (3.9%) | 65 (5.6%) | 9 (7.0%) |
| Hypoproteinemia | 223 (19.2%) | 26 (20.3%) | 224 (19.3%) | 25 (19.5%) |
| Monoclonal gammopathy | 235 (20.2%) | 29 (22.7%) | 240 (20.7%) | 24 (18.8%) |
| Nephrotic syndrome | 149 (12.8%) | 16 (12.5%) | 144 (12.4%) | 21 (16.4%) |
| Polyclonal gammopathy | 222 (19.1%) | 22 (17.2%) | 224 (19.3%) | 20 (15.6%) |
| Normal | 263 (22.7%) | 30 (23.4%) | 264 (22.7%) | 29 (22.7%) |
Values are presented as median (interquartile range).
Comparisons of the area under the receiver operating characteristic curve (AUC) of Inception V3, Xception, and DenseNET-121 to identify patterns of protein electrophoresis images.
| Densitogram EP image | Gel EP image | |||||
|---|---|---|---|---|---|---|
| Inception V3 | Xception | DenseNET-121 | Inception V3 | Xception | DenseNET-121 | |
| Acute phase protein | 0.647 | 0.826 | 0.873 | 0.767 | 0.665 | 0.763 |
| Hypoproteinemia | 0.833 | 0.856 | 0.891 | 0.888 | 0.879 | 0.863 |
| Monoclonal gammopathy | 0.970 | 0.952 | 0.979 | 0.920 | 0.920 | 0.897 |
| Nephrotic syndrome | 0.936 | 0.963 | 0.967 | 0.894 | 0.910 | 0.919 |
| Polyclonal gammopathy | 0.993 | 0.991 | 0.989 | 0.942 | 0.977 | 0.965 |
| Normal | 0.942 | 0.933 | 0.927 | 0.933 | 0.934 | 0.929 |
Summary of performance, including AUROC, for each finding in the database.
| (A) Densitogram EP image | ||||||
| Metric | ||||||
| Sensitivity | Specificity | AUROC | Accuracy | PPV | NPV | |
| Acute phase protein | 0.600 | 0.951 | 0.873 | 0.937 | 0.333 | 0.983 |
| Hypoproteinemia | 0.846 | 0.853 | 0.891 | 0.852 | 0.595 | 0.956 |
| Monoclonal gammopathy | 0.862 | 1.000 | 0.979 | 0.969 | 1.000 | 0.961 |
| Nephrotic syndrome | 0.687 | 0.991 | 0.967 | 0.953 | 0.917 | 0.957 |
| Polyclonal gammopathy | 0.818 | 0.981 | 0.989 | 0.953 | 0.900 | 0.963 |
| Normal | 0.667 | 0.949 | 0.927 | 0.883 | 0.800 | 0.903 |
| (B) Gel EP image | ||||||
| Metric | ||||||
| Sensitivity | Specificity | AUROC | Accuracy | PPV | NPV | |
| Acute phase protein | 0.222 | 0.882 | 0.763 | 0.836 | 0.125 | 0.938 |
| Hypoproteinemia | 0.520 | 0.893 | 0.863 | 0.820 | 0.542 | 0.885 |
| Monoclonal gammopathy | 0.792 | 0.981 | 0.897 | 0.945 | 0.905 | 0.953 |
| Nephrotic syndrome | 0.238 | 0.972 | 0.919 | 0.852 | 0.625 | 0.867 |
| Polyclonal gammopathy | 0.800 | 0.917 | 0.965 | 0.898 | 0.640 | 0.961 |
| Normal | 0.759 | 0.879 | 0.929 | 0.852 | 0.647 | 0.926 |
Fig 2ROC curves for classification of diagnosis from PEP images.
(A) densitogram EP images and (B) gel EP images.
Confusion Matrix for disease diagnosis from the PEP dataset.
| (A) Densitogram EP image | |||||||
| Label | Prediction | ||||||
| APR | Hypoproteinemia | Monoclonal gammopathy | Nephrotic syndrome | Polyclonal gammopathy | Normal | Total | |
| APR | 3 | 1 | 0 | 1 | 0 | 0 | 5 |
| Hypoproteinemia | 2 | 22 | 0 | 0 | 0 | 2 | 26 |
| Monoclonal gammopathy | 0 | 2 | 25 | 0 | 1 | 1 | 29 |
| Nephrotic syndrome | 2 | 3 | 0 | 11 | 0 | 0 | 16 |
| Polyclonal gammophathy | 0 | 2 | 0 | 0 | 18 | 2 | 22 |
| Normal | 2 | 7 | 0 | 0 | 1 | 20 | 30 |
| Total | 9 | 37 | 25 | 12 | 20 | 25 | 128 |
| (B) Gel EP | |||||||
| Label | Prediction | ||||||
| APR | Hypoproteinemia | Monoclonal gammopathy | Nephrotic syndrome | Polyclonal gammopathy | Normal | Total | |
| APR | 2 | 3 | 0 | 1 | 1 | 2 | 9 |
| Hypoproteinemia | 2 | 13 | 0 | 1 | 4 | 5 | 25 |
| Monoclonal gammopathy | 1 | 1 | 19 | 1 | 1 | 1 | 24 |
| Nephrotic syndrome | 9 | 4 | 1 | 5 | 1 | 1 | 21 |
| Polyclonal gammophathy | 0 | 0 | 1 | 0 | 16 | 3 | 20 |
| Normal | 2 | 3 | 0 | 0 | 2 | 22 | 29 |
| Total | 16 | 24 | 21 | 8 | 25 | 34 | 128 |
Fig 3Representative true and false-positive case images results from Gradient-weighted Class Activation Mapping (Grad-CAM), obtained using DenseNET-121 classification model.
(A) and (B) show true positive cases with a definite monoclonal peak and small monoclonal peak, respectively. Patients A and B showed 4.3g/dL and 1.1g/dL M-peaks (IgG, kappa type pattern with immunofixation assay). Monoclonal gammopathy cases were incorrectly predicted as polyclonal gammopathy (C) and normal (D). Patient C showed a 0.7 g/dL M-peak (IgG, lambda), and patient D showed a 0.6g/dL M-peak (bi-clonal band with IgG, kappa).